Solid Biosciences Shares Update on SGT-001 Phase I/II Clinical Hold for IGNITE DMD Program
Solid Biosciences shared today that their IGNITE DMD Phase I/II clinical trial will remain on clinical hold. Solid will continue to work with the FDA to provide further data and analyses relating to their manufacturing…Learn More